Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamotrigine vs Gabapentin in Refractory Mood Disorders
NCT00001482Phase 2Completed
- Sponsor
- National Institute of Mental Health
- Start
- May 1995
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in mood disorder comparing Lamotrigine Monotherapy with Gabapentin Monotherapy (2 arms). Primary endpoint: Response Rate at 6 weeks. Started May 1995; status: completed.
02
Drugs
lamotriginegabapentin
03
Conditions
mood disorder
Beyond the preview
Go deeper on NCT00001482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001482.